开云app官网登录入口网页版-官方正版

#Graves#

37篇内容 | 1431人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2039619, encodeId=709f2039619ce, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=甲亢治疗中最易被忽略的一环！《2021年欧洲Graves眼病临床实践管理指南》解读, objectType=article, longId=735191, objectId=e73fe3519133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e73fe3519133, replyNumber=0, likeNumber=80, createdTime=2022-09-27, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e73fe3519133, moduleTitle=甲亢治疗中最易被忽略的一环！《2021年欧洲Graves眼病临床实践管理指南》解读, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e73fe3519133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039613, encodeId=081d203961339, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=Front Endocrinol：丙基硫氧嘧啶和甲巯咪唑治疗Graves病对血管粥样硬化标志物的不同影响, objectType=article, longId=293874, objectId=b91d2938e4dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b91d2938e4dd, replyNumber=0, likeNumber=76, createdTime=2022-03-03, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b91d2938e4dd, moduleTitle=Front Endocrinol：丙基硫氧嘧啶和甲巯咪唑治疗Graves病对血管粥样硬化标志物的不同影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b91d2938e4dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039615, encodeId=15ea203961524, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=JCLA:ELISA和斑点印迹法检测Graves病TSH受体抗体的比较, objectType=article, longId=299555, objectId=bc37299555c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc37299555c5, replyNumber=0, likeNumber=74, createdTime=2023-02-01, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc37299555c5, moduleTitle=JCLA:ELISA和斑点印迹法检测Graves病TSH受体抗体的比较, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bc37299555c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039614, encodeId=5de020396140e, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=JCEM：Graves’病引起甲状腺功能亢进引起的睡眠障碍与交感亢进相关, objectType=article, longId=294884, objectId=52bd2948845d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52bd2948845d, replyNumber=0, likeNumber=86, createdTime=2022-08-06, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52bd2948845d, moduleTitle=JCEM：Graves’病引起甲状腺功能亢进引起的睡眠障碍与交感亢进相关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=52bd2948845d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039618, encodeId=36ad203961870, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=Cureus：严重中性粒细胞减少症Graves病的治疗。, objectType=article, longId=299966, objectId=82fe299966ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82fe299966ea, replyNumber=0, likeNumber=80, createdTime=2022-06-26, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82fe299966ea, moduleTitle=Cureus：严重中性粒细胞减少症Graves病的治疗。, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=82fe299966ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039617, encodeId=c6dd203961e87, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=Cureus：严重中性粒细胞减少症Graves病的治疗, objectType=article, longId=299560, objectId=6e28299560f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e28299560f4, replyNumber=0, likeNumber=70, createdTime=2022-05-17, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e28299560f4, moduleTitle=Cureus：严重中性粒细胞减少症Graves病的治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6e28299560f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039616, encodeId=33ac203961600, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=BMC Gastroenterol：Graves病与慢性乙型肝炎、甲巯咪唑所致肝损伤及自身免疫性肝炎重叠1例, objectType=article, longId=299557, objectId=33e129955e79, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33e129955e79, replyNumber=0, likeNumber=92, createdTime=2022-10-22, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33e129955e79, moduleTitle=BMC Gastroenterol：Graves病与慢性乙型肝炎、甲巯咪唑所致肝损伤及自身免疫性肝炎重叠1例, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=33e129955e79)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039605, encodeId=9d4c203960597, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=Thyroid：Graves病患者长期服用甲巯咪唑后的缓解率增加, objectType=article, longId=217020, objectId=76cb21e02073, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76cb21e02073, replyNumber=0, likeNumber=73, createdTime=2021-10-14, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76cb21e02073, moduleTitle=Thyroid：Graves病患者长期服用甲巯咪唑后的缓解率增加, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=76cb21e02073)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039601, encodeId=25e020396014d, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=Eur J Endocrinol：放射性碘治疗后的Graves甲亢患者早期预防性的使用左甲状腺素可以改善其生活质量 , objectType=article, longId=216673, objectId=0ad92166e3e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ad92166e3e3, replyNumber=0, likeNumber=73, createdTime=2021-10-06, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ad92166e3e3, moduleTitle=Eur J Endocrinol：放射性碘治疗后的Graves甲亢患者早期预防性的使用左甲状腺素可以改善其生活质量 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0ad92166e3e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039610, encodeId=3e9c203961059, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=Thyroid：甲状腺辐射吸收剂量与放射性碘治疗Graves病疗效关系的系统回顾和荟萃分析, objectType=article, longId=219084, objectId=1413219084d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1413219084d0, replyNumber=0, likeNumber=82, createdTime=2022-07-08, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1413219084d0, moduleTitle=Thyroid：甲状腺辐射吸收剂量与放射性碘治疗Graves病疗效关系的系统回顾和荟萃分析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1413219084d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039612, encodeId=d43c2039612ab, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=JCEM:利妥昔单抗辅助治疗在青年Graves病中的探索性试验, objectType=article, longId=221217, objectId=daf222121ee2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=daf222121ee2, replyNumber=0, likeNumber=84, createdTime=2021-12-06, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=daf222121ee2, moduleTitle=JCEM:利妥昔单抗辅助治疗在青年Graves病中的探索性试验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=daf222121ee2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039603, encodeId=1b15203960336, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=JCEM：利妥昔单抗在治疗Graves眼病患者中没有获益？, objectType=article, longId=216732, objectId=b3fe216e3245, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3fe216e3245, replyNumber=0, likeNumber=101, createdTime=2022-03-19, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3fe216e3245, moduleTitle=JCEM：利妥昔单抗在治疗Graves眼病患者中没有获益？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b3fe216e3245)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039608, encodeId=943b2039608dd, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=Thyroid:Graves眼病患者使用前列腺素F2-α滴眼液（比马前列素）, objectType=article, longId=217495, objectId=8b2921e49547, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b2921e49547, replyNumber=0, likeNumber=88, createdTime=2022-06-16, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b2921e49547, moduleTitle=Thyroid:Graves眼病患者使用前列腺素F2-α滴眼液（比马前列素）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8b2921e49547)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039611, encodeId=94252039611fb, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=Lancet Diabetes Endocrinol：他汀类药物对Graves病(STAGO)预后如何？, objectType=article, longId=219374, objectId=1ffa2193e43c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ffa2193e43c, replyNumber=0, likeNumber=77, createdTime=2021-12-15, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ffa2193e43c, moduleTitle=Lancet Diabetes Endocrinol：他汀类药物对Graves病(STAGO)预后如何？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1ffa2193e43c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039602, encodeId=994a203960236, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=JCEM：利妥昔单抗靶向治疗在活动性中度至重度Graves眼病患者的疗效, objectType=article, longId=216674, objectId=c00c2166e4fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c00c2166e4fb, replyNumber=0, likeNumber=77, createdTime=2022-07-03, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c00c2166e4fb, moduleTitle=JCEM：利妥昔单抗靶向治疗在活动性中度至重度Graves眼病患者的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c00c2166e4fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039604, encodeId=76b02039604dc, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=Thyroid ：对比抗甲状腺药物，补充维生素D对Graves病患者的肌肉和生活质量的影响, objectType=article, longId=216991, objectId=286221699118, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=286221699118, replyNumber=0, likeNumber=112, createdTime=2022-05-29, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=286221699118, moduleTitle=Thyroid ：对比抗甲状腺药物，补充维生素D对Graves病患者的肌肉和生活质量的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=286221699118)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039606, encodeId=d9f8203960650, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=Heart：Graves'病患者心衰发生率、危险因素、病程和结局, objectType=article, longId=217122, objectId=6be521e12272, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6be521e12272, replyNumber=0, likeNumber=73, createdTime=2021-09-28, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6be521e12272, moduleTitle=Heart：Graves'病患者心衰发生率、危险因素、病程和结局, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6be521e12272)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039609, encodeId=0aaf203960960, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=Heart：Graves病相关心力衰竭的发生率、危险因素、自然病史和预后, objectType=article, longId=219024, objectId=123a21902422, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=123a21902422, replyNumber=0, likeNumber=79, createdTime=2022-08-24, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=123a21902422, moduleTitle=Heart：Graves病相关心力衰竭的发生率、危险因素、自然病史和预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=123a21902422)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039607, encodeId=a2c8203960e71, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=Thyroid:短期口服或静脉使用激素预防放射性碘消融术Graves病患者眼病的进展, objectType=article, longId=217528, objectId=878d21e52831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=878d21e52831, replyNumber=0, likeNumber=76, createdTime=2022-08-24, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=878d21e52831, moduleTitle=Thyroid:短期口服或静脉使用激素预防放射性碘消融术Graves病患者眼病的进展, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=878d21e52831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2039600, encodeId=58d0203960062, content=<a href='/topic/show?id=7ae88244a6' target=_blank style='color:#2F92EE;'>#Graves#</a>, objectTitle=HBM9161针对Graves眼病的临床试验获NMPA批件, objectType=article, longId=195214, objectId=8696195214be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8696195214be, replyNumber=0, likeNumber=75, createdTime=2020-07-09, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8696195214be, moduleTitle=HBM9161针对Graves眼病的临床试验获NMPA批件, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8696195214be)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

Graves

2020-05-29

docwu2019 (审核中...)

前往app查看评论内容

#Graves#

甲亢治疗中最易被忽略的一环！《2021年欧洲Graves眼病临床实践管理指南》解读

2022-09-27

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

Front Endocrinol：丙基硫氧嘧啶和甲巯咪唑治疗Graves病对血管粥样硬化标志物的不同影响

2022-03-03

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

JCLA:ELISA和斑点印迹法检测Graves病TSH受体抗体的比较

2023-02-01

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

JCEM：Graves’病引起甲状腺功能亢进引起的睡眠障碍与交感亢进相关

2022-08-06

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

Cureus：严重中性粒细胞减少症Graves病的治疗。

2022-06-26

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

Cureus：严重中性粒细胞减少症Graves病的治疗

2022-05-17

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

BMC Gastroenterol：Graves病与慢性乙型肝炎、甲巯咪唑所致肝损伤及自身免疫性肝炎重叠1例

2022-10-22

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

Thyroid：Graves病患者长期服用甲巯咪唑后的缓解率增加

2021-10-14

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

Eur J Endocrinol：放射性碘治疗后的Graves甲亢患者早期预防性的使用左甲状腺素可以改善其生活质量

2021-10-06

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

Thyroid：甲状腺辐射吸收剂量与放射性碘治疗Graves病疗效关系的系统回顾和荟萃分析

2022-07-08

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

JCEM:利妥昔单抗辅助治疗在青年Graves病中的探索性试验

2021-12-06

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

JCEM：利妥昔单抗在治疗Graves眼病患者中没有获益？

2022-03-19

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

Thyroid:Graves眼病患者使用前列腺素F2-α滴眼液（比马前列素）

2022-06-16

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

Lancet Diabetes Endocrinol：他汀类药物对Graves病(STAGO)预后如何？

2021-12-15

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

JCEM：利妥昔单抗靶向治疗在活动性中度至重度Graves眼病患者的疗效

2022-07-03

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

Thyroid ：对比抗甲状腺药物，补充维生素D对Graves病患者的肌肉和生活质量的影响

2022-05-29

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

Heart：Graves'病患者心衰发生率、危险因素、病程和结局

2021-09-28

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

Heart：Graves病相关心力衰竭的发生率、危险因素、自然病史和预后

2022-08-24

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

Thyroid:短期口服或静脉使用激素预防放射性碘消融术Graves病患者眼病的进展

2022-08-24

智者为医08 (审核中...)

前往app查看评论内容

#Graves#

HBM9161针对Graves眼病的临床试验获NMPA批件

2020-07-09

科室
- - 订阅+
  - 更多科室
工具
服务